|
|
||||||||
1Institut National de la Santé et de la Recherche Médicale Unité 367, Physiologie et Pathologie Expérimentale Vasculaires, Université Paris VI, 75005 Paris; and 2Laboratoire de Biologie Intégrée des Cellules Rénales, Unité de Recherche Associée 1859 au Centre National de la Recherche Scientifique, Commissariat a l'Energie Atomique-Saclay, 91191 Gif-sur-Yvette, France
Submitted 19 December 2002 ; accepted in final form 2 May 2003
ANG II controls the vascular tone of pre- and postglomerular arterioles, and thereby glomerular filtration, through binding to either AT1A, AT1B, or AT2 receptors. AT1 receptors, which are coupled to intracellular Ca2+ signaling, have vasoconstricting effects, whereas AT2 receptors, whose signaling mechanism is unknown, induce vasodilatation. The angiotensin receptors have been characterized in afferent arterioles, which express the three types of receptors, but not in efferent arterioles. Two subpopulations of juxtamedullary efferent arterioles, muscular ones which terminate as vasa rectae and thin ones which terminate as peritubular capillaries, have been described. They display functional heterogeneity with regard to the ANG II response. To evaluate whether these differences are associated with differential expression of ANG II receptors, we examined the expression pattern of AT1A, AT1B, and AT2 receptor mRNAs by RT-PCR in these arterioles and studied the effect of valsartan, a specific AT1-receptor antagonist. Results indicate that muscular arterioles express AT1A, AT1B, and AT2 receptors, whereas thin arterioles only express the AT1A and AT2 types, and at a much lower level. Valsartan fully inhibited ANG II-induced increases in intracellular Ca2+ in both arteriolar types, but with different kinetics. In muscular arterioles, inhibition was monoexponential, whereas it displayed a marked positive cooperativity in thin arterioles. Finally, the apparent affinity for valsartan was higher in muscular than in thin arterioles. In conclusion, this study further documents the differences between muscular and thin efferent arterioles with regard to ANG II signalization in the rat kidney.
angiotensin II; valsartan; calcium signaling
This article has been cited by other articles:
![]() |
S. Fujimoto, M. Satoh, H. Nagasu, H. Horike, T. Sasaki, and N. Kashihara Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3651 - 3658. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Razga and J. R. Nyengaard Up- and down-regulation of angiotensin II AT1-A and AT1-B receptors in afferent and efferent rat kidney arterioles Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 196 - 201. [Abstract] [PDF] |
||||
![]() |
L. M. Harrison-Bernard, C. J. Monjure, and B. J. Bivona Efferent arterioles exclusively express the subtype 1A angiotensin receptor: functional insights from genetic mouse models Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1177 - F1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sahajpal and N. Ashton Increased glomerular angiotensin II binding in rats exposed to a maternal low protein diet in utero J. Physiol., February 15, 2005; 563(1): 193 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gonzalez-Villalobos, R. B. Klassen, P. L. Allen, L. G. Navar, and T. G. Hammond Megalin binds and internalizes angiotensin II Am J Physiol Renal Physiol, February 1, 2005; 288(2): F420 - F427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |